Delivery Order SPE2DB25D3202-SPE2DB25FTAJJ

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $2,413.19 and a period of performance through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.92, is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" and has a completion date of April 10, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.25, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a period of performance through April 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product, with a ceiling value of $1,867.19 and a completion date of May 2, 2024. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,235.61, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,905.90 contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.95, is for the supply of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", with a ceiling value of $1,145.94 and a period of performance through January 9, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price, a ceiling value of $1,014.55, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FTAJJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a ceiling value of $1,147.00. The contract is a firm fixed-price delivery order with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This contract is not set aside for any specific business category.

Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:13 AM